文献速递乳腺USMR乳腺X线

影像学应答评估在乳腺癌新辅助全身治疗调整中的作用:系统综述

Role of imaging based response assesment for adapting neoadjuvant systemic therapy for breast cancer: A systematic review.
PubMed 文献 · Eur J Radiol · 2025-04-08

本系统综述分析5部临床实践指南和147篇临床试验文献,评估影像学在乳腺癌新辅助全身治疗应答监测中的作用及基于影像应答调整治疗的实施情况。81%(119/147)的试验使用影像学,56%(83/147)进行中期影像评估,仅15%(22/147)基于影像应答调整治疗;各试验和指南间影像方法、时机和应答标准差异很大,无标准化方案。

要点

  • 81%(119/147)的试验使用影像学监测新辅助治疗应答,最常用超声、MRI和乳腺X线。
  • 仅15%(22/147)的试验基于影像应答调整治疗,影像引导治疗应用有限。
  • 各试验和指南间影像方法、时机及应答标准差异很大,无标准化方案。

核心结论

  • 本系统综述强调亟需标准化的影像学方案、应答评估标准和影像引导的治疗决策,目前治疗期间的影像应答监测最好在临床试验内进行。

研究设计与样本

  • 系统综述,采用滚雪球技术以临床指南为起始集追溯相关试验,并检索PubMed纳入2023-2024年发表的试验,共分析5部临床实践指南和147篇临床试验文献。

诊断标准与关键数值

  • 81%(119/147)的试验使用了影像学,最常用为超声、MRI和乳腺X线。
  • 56%(83/147)的试验进行了治疗中期影像评估。
  • 仅15%(22/147)的试验基于影像应答实施治疗调整。
  • 各试验和临床实践指南间未识别出标准化的影像方案或一致的应答引导治疗策略。

临床应用与阅片要点

  • 作者认为亟需标准化的影像学方案、应答评估标准和影像引导的治疗决策。
  • 作者认为治疗期间的影像应答监测最好在临床试验内进行。

局限性

  • 各试验和临床实践指南间未识别出标准化的影像方案或一致的应答引导治疗策略,影像方法、时机和应答标准存在相当大的变异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The objective of this systematic review is to investigate the role of imaging in response monitoring during neoadjuvant systemic therapy (NST) for breast cancer and assess whether treatment modifications based on imaging response are implemented in clinical practice.

METHODS: A systematic review was conducted, analyzing five clinical practice guidelines and 147 clinical trial publications involving NST for breast cancer. The snowballing technique was employed, using a "start set" of clinical guidelines to trace relevant trials. Additionally, a PubMed search was conducted to identify trials published between 2023-2024. The review analyzed the use of imaging modalities, timing, and response criteria, and whether escalation, de-escalation, or change of treatment occurred based on imaging response.

RESULTS: Imaging was utilized in 81 % (119/147) of the trials, with ultrasound, MRI, and mammography being the most frequently employed modalities. Mid-treatment imaging was applied in 56 % (83/147) of the trials. However, only 15 % (22/147) of the trials implemented treatment modifications based on imaging response, highlighting the limited application of imaging response-guided therapy. No standardized imaging protocols or consistent response-guided treatment strategies were identified across the trials or clinical practice guidelines, with considerable variability in imaging methods, timing, and response criteria.

CONCLUSION: This systematic review underscores the critical need for standardized imaging protocols, response assessment criteria and image-guided treatment decisions. It is therefore evident that imaging for response monitoring during treatment should preferably be performed within clinical trials.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Lafci O, Resch D, Santonocito A, et al. Role of imaging based response assesment for adapting neoadjuvant systemic therapy for breast cancer: A systematic review. Eur J Radiol. 2025. PMID: 40252279. doi:10.1016/j.ejrad.2025.112105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。